Description
Premedication strategy for paclitaxel, still an unsolved question after 30 years
Article: Premedication strategy for paclitaxel, still an unsolved question after 30 years
€2.42
Related products
-
Article: Highlights in genitourinary cancers
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Calendar of events
€2.42 Add to cart -
Article: INTRODUCTION
€2.42 Add to cart
